A Phase 1 interventional study of Treatment with chemotherapy and Only chemotherapy treatment for study cohort in Colorectal Cancer, sponsored by Centro Hospitalar Nordeste. Completed. Open to participants aged 40 Years to 90 Years. Per ClinicalTrials.gov, last updated 2011-10-21.
Sponsored by Centro Hospitalar Nordeste · Phase 1, Interventional, and Treatment
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
Browse Colorectal Neoplasms studies →This is the only study on the registry with Centro Hospitalar Nordeste as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients treated with chemotherapy + surgery
Other: Treatment with chemotherapy · Procedure: surgery
Patients treated only with chemotherapy
Other: Only chemotherapy treatment for study cohort
Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy
No study locations are listed for this record.
This study is completed, as verified in Sep 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.